These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 20861719)
1. Pharmacotherapy of atrial fibrillation: a pathophysiological perspective and review. Jacob S; Ali OA; Pidlaoan V; Badheka AO; Kerin NZ Am J Ther; 2011 May; 18(3):241-60. PubMed ID: 20861719 [TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic therapy in atrial fibrillation. Ravens U Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425 [TBL] [Abstract][Full Text] [Related]
3. New pharmacological targets and treatments for atrial fibrillation. Carlsson L; Duker G; Jacobson I Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645 [TBL] [Abstract][Full Text] [Related]
4. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence. Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078 [TBL] [Abstract][Full Text] [Related]
5. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Savelieva I; Kakouros N; Kourliouros A; Camm AJ Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926 [TBL] [Abstract][Full Text] [Related]
6. [Cardiac two-pore-domain potassium channels (K2P): Physiology, pharmacology, and therapeutic potential]. Schmidt C; Wiedmann F; Schweizer PA; Katus HA; Thomas D Dtsch Med Wochenschr; 2012 Aug; 137(33):1654-8. PubMed ID: 22875694 [TBL] [Abstract][Full Text] [Related]
8. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches]. Runge S; Dietz R; Haverkamp W Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713 [TBL] [Abstract][Full Text] [Related]